Concepts (169)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Peripheral Arterial Disease | 11 | 2026 | 110 | 2.730 |
Why?
|
| Endovascular Procedures | 10 | 2025 | 399 | 2.400 |
Why?
|
| Blood Vessel Prosthesis Implantation | 9 | 2025 | 246 | 2.060 |
Why?
|
| Decision Support Techniques | 7 | 2026 | 194 | 1.800 |
Why?
|
| Lower Extremity | 5 | 2025 | 108 | 1.580 |
Why?
|
| Vascular Grafting | 5 | 2026 | 21 | 1.570 |
Why?
|
| Aortic Rupture | 3 | 2025 | 53 | 1.190 |
Why?
|
| Ischemia | 3 | 2025 | 262 | 1.130 |
Why?
|
| Aortic Aneurysm, Thoracic | 3 | 2025 | 101 | 1.120 |
Why?
|
| Aortic Aneurysm, Abdominal | 5 | 2022 | 125 | 1.060 |
Why?
|
| Aorta, Thoracic | 2 | 2024 | 154 | 0.930 |
Why?
|
| Pseudomonas Infections | 4 | 2012 | 94 | 0.850 |
Why?
|
| Pseudomonas aeruginosa | 5 | 2012 | 206 | 0.850 |
Why?
|
| Frail Elderly | 1 | 2024 | 96 | 0.800 |
Why?
|
| Transcatheter Aortic Valve Replacement | 1 | 2024 | 80 | 0.800 |
Why?
|
| Frailty | 1 | 2024 | 103 | 0.750 |
Why?
|
| Risk Factors | 18 | 2026 | 6233 | 0.650 |
Why?
|
| Healthcare Disparities | 2 | 2025 | 539 | 0.620 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2025 | 659 | 0.610 |
Why?
|
| Risk Assessment | 13 | 2026 | 2585 | 0.590 |
Why?
|
| Treatment Outcome | 17 | 2026 | 9711 | 0.560 |
Why?
|
| Femoral Artery | 3 | 2026 | 96 | 0.550 |
Why?
|
| Time Factors | 13 | 2026 | 5567 | 0.530 |
Why?
|
| Blood Vessel Prosthesis | 6 | 2024 | 255 | 0.520 |
Why?
|
| Vascular Patency | 3 | 2026 | 123 | 0.510 |
Why?
|
| Graft Occlusion, Vascular | 3 | 2026 | 92 | 0.500 |
Why?
|
| Databases, Factual | 6 | 2026 | 1094 | 0.480 |
Why?
|
| Retrospective Studies | 18 | 2026 | 10973 | 0.430 |
Why?
|
| Aortic Diseases | 2 | 2026 | 88 | 0.430 |
Why?
|
| Postoperative Complications | 7 | 2024 | 2681 | 0.410 |
Why?
|
| Aneurysm | 1 | 2013 | 59 | 0.380 |
Why?
|
| Aged, 80 and over | 10 | 2025 | 7389 | 0.370 |
Why?
|
| Peritonitis | 1 | 2012 | 28 | 0.370 |
Why?
|
| Opportunistic Infections | 1 | 2012 | 57 | 0.360 |
Why?
|
| Adhesins, Bacterial | 1 | 2012 | 37 | 0.350 |
Why?
|
| Lectins | 1 | 2012 | 82 | 0.350 |
Why?
|
| Morphine | 1 | 2012 | 127 | 0.330 |
Why?
|
| Hepatectomy | 1 | 2012 | 203 | 0.330 |
Why?
|
| Aged | 17 | 2026 | 21758 | 0.330 |
Why?
|
| Sepsis | 3 | 2012 | 427 | 0.330 |
Why?
|
| Intestines | 3 | 2012 | 441 | 0.330 |
Why?
|
| Limb Salvage | 3 | 2026 | 43 | 0.320 |
Why?
|
| Popliteal Artery | 2 | 2023 | 32 | 0.290 |
Why?
|
| Middle Aged | 15 | 2026 | 29428 | 0.260 |
Why?
|
| Predictive Value of Tests | 4 | 2026 | 1782 | 0.260 |
Why?
|
| Aorta | 2 | 2026 | 275 | 0.250 |
Why?
|
| Intestinal Mucosa | 1 | 2012 | 834 | 0.250 |
Why?
|
| Stents | 3 | 2022 | 433 | 0.250 |
Why?
|
| Emergencies | 2 | 2024 | 122 | 0.250 |
Why?
|
| Analgesics, Opioid | 1 | 2012 | 540 | 0.250 |
Why?
|
| Sex Factors | 3 | 2025 | 1138 | 0.240 |
Why?
|
| Humans | 27 | 2026 | 98080 | 0.240 |
Why?
|
| Male | 18 | 2026 | 47076 | 0.230 |
Why?
|
| Prosthesis Design | 4 | 2022 | 308 | 0.230 |
Why?
|
| Iliac Artery | 1 | 2026 | 44 | 0.230 |
Why?
|
| Arterial Occlusive Diseases | 1 | 2026 | 107 | 0.220 |
Why?
|
| Female | 18 | 2026 | 51536 | 0.220 |
Why?
|
| Punctures | 1 | 2024 | 29 | 0.220 |
Why?
|
| Socioeconomic Factors | 2 | 2024 | 663 | 0.220 |
Why?
|
| Artificial Limbs | 1 | 2024 | 17 | 0.210 |
Why?
|
| Heart Valve Prosthesis | 1 | 2024 | 97 | 0.210 |
Why?
|
| Thrombectomy | 1 | 2026 | 260 | 0.200 |
Why?
|
| Saphenous Vein | 1 | 2023 | 61 | 0.200 |
Why?
|
| Random Allocation | 3 | 2012 | 311 | 0.200 |
Why?
|
| Geriatric Assessment | 1 | 2024 | 193 | 0.190 |
Why?
|
| Virulence | 3 | 2012 | 280 | 0.190 |
Why?
|
| Acute Disease | 1 | 2024 | 860 | 0.190 |
Why?
|
| Aortic Valve | 1 | 2024 | 258 | 0.180 |
Why?
|
| Workload | 1 | 2023 | 130 | 0.180 |
Why?
|
| Recovery of Function | 1 | 2024 | 370 | 0.180 |
Why?
|
| Myocardial Infarction | 1 | 2025 | 396 | 0.170 |
Why?
|
| Self Expandable Metallic Stents | 1 | 2020 | 7 | 0.170 |
Why?
|
| Longitudinal Studies | 1 | 2024 | 1284 | 0.160 |
Why?
|
| Situs Inversus | 1 | 2020 | 16 | 0.160 |
Why?
|
| Aortography | 1 | 2020 | 60 | 0.160 |
Why?
|
| Jehovah's Witnesses | 1 | 2020 | 21 | 0.160 |
Why?
|
| Catheterization, Peripheral | 1 | 2020 | 62 | 0.160 |
Why?
|
| Aortic Aneurysm | 1 | 2020 | 72 | 0.160 |
Why?
|
| Upper Extremity | 1 | 2020 | 69 | 0.150 |
Why?
|
| Computed Tomography Angiography | 1 | 2020 | 188 | 0.140 |
Why?
|
| Surgeons | 1 | 2023 | 325 | 0.140 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 1 | 2020 | 462 | 0.130 |
Why?
|
| Kaplan-Meier Estimate | 3 | 2018 | 903 | 0.120 |
Why?
|
| Vascular Surgical Procedures | 2 | 2023 | 166 | 0.120 |
Why?
|
| Phosphates | 3 | 2012 | 165 | 0.120 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2020 | 630 | 0.120 |
Why?
|
| Physicians | 1 | 2021 | 685 | 0.100 |
Why?
|
| Brachial Artery | 1 | 2013 | 37 | 0.100 |
Why?
|
| Caenorhabditis elegans | 3 | 2012 | 256 | 0.100 |
Why?
|
| Mice | 6 | 2012 | 12698 | 0.100 |
Why?
|
| Aneurysm, False | 1 | 2013 | 52 | 0.100 |
Why?
|
| Axilla | 1 | 2013 | 109 | 0.090 |
Why?
|
| Ultrasonography, Interventional | 1 | 2013 | 126 | 0.090 |
Why?
|
| Social Determinants of Health | 2 | 2024 | 132 | 0.090 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 2012 | 85 | 0.090 |
Why?
|
| Algorithms | 1 | 2020 | 2002 | 0.090 |
Why?
|
| Candida albicans | 1 | 2012 | 32 | 0.090 |
Why?
|
| Leiomyomatosis | 1 | 2012 | 15 | 0.090 |
Why?
|
| Chemotaxis | 1 | 2012 | 77 | 0.090 |
Why?
|
| Virulence Factors | 1 | 2012 | 117 | 0.080 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2012 | 301 | 0.080 |
Why?
|
| Phenotype | 3 | 2012 | 2638 | 0.080 |
Why?
|
| Vena Cava, Inferior | 1 | 2012 | 140 | 0.080 |
Why?
|
| Reperfusion Injury | 1 | 2011 | 148 | 0.080 |
Why?
|
| Mice, Inbred C57BL | 3 | 2012 | 3598 | 0.080 |
Why?
|
| Metagenome | 1 | 2011 | 123 | 0.080 |
Why?
|
| Gastrointestinal Tract | 1 | 2012 | 198 | 0.080 |
Why?
|
| Intestine, Small | 1 | 2011 | 318 | 0.080 |
Why?
|
| Endoleak | 2 | 2021 | 45 | 0.070 |
Why?
|
| Stress, Physiological | 1 | 2011 | 256 | 0.070 |
Why?
|
| Cytokines | 1 | 2012 | 889 | 0.070 |
Why?
|
| Critical Illness | 1 | 2012 | 436 | 0.070 |
Why?
|
| Animals | 6 | 2012 | 28894 | 0.070 |
Why?
|
| Uterine Neoplasms | 1 | 2012 | 289 | 0.060 |
Why?
|
| Comorbidity | 2 | 2023 | 1033 | 0.060 |
Why?
|
| United States | 3 | 2024 | 8197 | 0.060 |
Why?
|
| Biomarkers | 1 | 2012 | 2020 | 0.060 |
Why?
|
| Anastomosis, Surgical | 1 | 2026 | 289 | 0.050 |
Why?
|
| Amputees | 1 | 2024 | 2 | 0.050 |
Why?
|
| Chi-Square Distribution | 2 | 2018 | 360 | 0.050 |
Why?
|
| Elective Surgical Procedures | 1 | 2026 | 171 | 0.050 |
Why?
|
| Registries | 2 | 2021 | 1122 | 0.050 |
Why?
|
| Relative Value Scales | 1 | 2023 | 13 | 0.050 |
Why?
|
| Treatment Failure | 1 | 2024 | 300 | 0.050 |
Why?
|
| Walking | 1 | 2024 | 114 | 0.050 |
Why?
|
| Vulnerable Populations | 1 | 2024 | 95 | 0.050 |
Why?
|
| Operative Time | 1 | 2023 | 175 | 0.050 |
Why?
|
| Coronary Artery Bypass | 1 | 2023 | 231 | 0.040 |
Why?
|
| Peru | 1 | 2021 | 28 | 0.040 |
Why?
|
| Medicaid | 1 | 2024 | 276 | 0.040 |
Why?
|
| Ultrasonography, Doppler, Duplex | 1 | 2020 | 42 | 0.040 |
Why?
|
| Medicare | 1 | 2024 | 467 | 0.040 |
Why?
|
| Patient-Specific Modeling | 1 | 2020 | 25 | 0.040 |
Why?
|
| Logistic Models | 1 | 2024 | 1275 | 0.040 |
Why?
|
| Finite Element Analysis | 1 | 2020 | 79 | 0.040 |
Why?
|
| Aneurysm, Ruptured | 1 | 2020 | 80 | 0.040 |
Why?
|
| Models, Cardiovascular | 1 | 2020 | 96 | 0.040 |
Why?
|
| Age Factors | 1 | 2024 | 1962 | 0.040 |
Why?
|
| Length of Stay | 1 | 2023 | 878 | 0.040 |
Why?
|
| Reproducibility of Results | 1 | 2025 | 2784 | 0.040 |
Why?
|
| Retreatment | 1 | 2018 | 107 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2020 | 2666 | 0.030 |
Why?
|
| Disease Models, Animal | 2 | 2011 | 2572 | 0.030 |
Why?
|
| Prognosis | 1 | 2020 | 4116 | 0.020 |
Why?
|
| Acid Phosphatase | 1 | 2012 | 28 | 0.020 |
Why?
|
| Bacterial Translocation | 1 | 2011 | 26 | 0.020 |
Why?
|
| Bacterial Adhesion | 1 | 2011 | 84 | 0.020 |
Why?
|
| Biofilms | 1 | 2012 | 52 | 0.020 |
Why?
|
| Microbiological Techniques | 1 | 2011 | 25 | 0.020 |
Why?
|
| Fungal Proteins | 1 | 2012 | 148 | 0.020 |
Why?
|
| Stroke | 1 | 2020 | 1154 | 0.020 |
Why?
|
| Genetic Techniques | 1 | 2011 | 74 | 0.020 |
Why?
|
| Reference Values | 1 | 2011 | 608 | 0.020 |
Why?
|
| Drug Design | 1 | 2011 | 135 | 0.020 |
Why?
|
| Intestinal Diseases | 1 | 2011 | 84 | 0.020 |
Why?
|
| Symbiosis | 1 | 2011 | 130 | 0.020 |
Why?
|
| Feces | 1 | 2012 | 387 | 0.020 |
Why?
|
| Color | 1 | 2009 | 80 | 0.020 |
Why?
|
| General Surgery | 1 | 2011 | 262 | 0.020 |
Why?
|
| Iron | 1 | 2009 | 178 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2011 | 1527 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 2012 | 911 | 0.020 |
Why?
|
| Genome, Bacterial | 1 | 2009 | 144 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2012 | 2896 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 2012 | 1133 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2012 | 4025 | 0.010 |
Why?
|
| Adult | 1 | 2020 | 29539 | 0.010 |
Why?
|
| Mutation | 1 | 2012 | 4392 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2012 | 3606 | 0.010 |
Why?
|